Evaluating Preclinical‐to‐Human Bioavailability Classification Using Smooth ROC Curve Estimation
ABSTRACT Human oral bioavailability is a critical pharmacokinetic parameter that determines systemic drug exposure, informs dose selection, and guides compound prioritization during early‐stage drug development. Although animal models are routinely employed to estimate human bioavailability, intersp...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wiley
2026-05-01
|
| Edice: | CPT: Pharmacometrics & Systems Pharmacology |
| Témata: | |
| On-line přístup: | https://doi.org/10.1002/psp4.70248 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
